EE200200152A - Antibody-dye conjugates for binding to target angiogenesis structures for intraoperative visualization of peripheral tumors - Google Patents

Antibody-dye conjugates for binding to target angiogenesis structures for intraoperative visualization of peripheral tumors

Info

Publication number
EE200200152A
EE200200152A EEP200200152A EEP200200152A EE200200152A EE 200200152 A EE200200152 A EE 200200152A EE P200200152 A EEP200200152 A EE P200200152A EE P200200152 A EEP200200152 A EE P200200152A EE 200200152 A EE200200152 A EE 200200152A
Authority
EE
Estonia
Prior art keywords
antibody
binding
structures
dye conjugates
intraoperative visualization
Prior art date
Application number
EEP200200152A
Other languages
Estonian (et)
Inventor
Schirner Michael
Licha Kai
Dinkelborg Ludger
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7924318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200152(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200152A publication Critical patent/EE200200152A/en
Publication of EE05176B1 publication Critical patent/EE05176B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039—Coumarin dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EEP200200152A 1999-09-24 2000-08-19 Antibody-v Dye Conjugates for Binding Target Angiogenesis Structures for Intraoperative Visualization of Tumor Realities EE05176B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947559A DE19947559A1 (en) 1999-09-24 1999-09-24 Antibody-dye conjugates against target structures of angiogenesis for intraoperative tumor border imaging
PCT/EP2000/008121 WO2001023005A1 (en) 1999-09-24 2000-08-19 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries

Publications (2)

Publication Number Publication Date
EE200200152A true EE200200152A (en) 2003-04-15
EE05176B1 EE05176B1 (en) 2009-06-15

Family

ID=7924318

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200152A EE05176B1 (en) 1999-09-24 2000-08-19 Antibody-v Dye Conjugates for Binding Target Angiogenesis Structures for Intraoperative Visualization of Tumor Realities

Country Status (23)

Country Link
EP (2) EP1214099A1 (en)
JP (1) JP2003510294A (en)
KR (2) KR100832937B1 (en)
CN (1) CN1269530C (en)
AU (1) AU779026B2 (en)
BG (1) BG65682B1 (en)
BR (1) BR0014192A (en)
CA (1) CA2385593A1 (en)
CZ (1) CZ2002991A3 (en)
DE (1) DE19947559A1 (en)
EE (1) EE05176B1 (en)
HK (1) HK1050491A1 (en)
HU (1) HUP0202625A2 (en)
IL (2) IL148405A0 (en)
MX (1) MXPA02002639A (en)
NO (1) NO20021441L (en)
NZ (1) NZ517944A (en)
RO (1) RO121598B1 (en)
RU (1) RU2002109237A (en)
SK (1) SK3972002A3 (en)
WO (1) WO2001023005A1 (en)
YU (1) YU20702A (en)
ZA (1) ZA200203225B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062800A1 (en) 2000-02-24 2001-08-30 Eidgenössische Technische Hochschule Zürich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
AT413487B (en) * 2002-08-12 2006-03-15 Igeneon Krebs Immuntherapie USE OF ANTIBODIES TO TUMOR ASSOCIATED ANTIGEN
NO20034351D0 (en) * 2003-09-29 2003-09-29 Amersham Health As Optical imaging of endometriosis
EP1816475A1 (en) * 2004-07-22 2007-08-08 Bayer Schering Pharma Aktiengesellschaft Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
EP2422187A4 (en) * 2009-04-21 2013-01-02 Univ Utah Res Found Light-emitting dye for intraoperative imaging or sentinel lymph node biopsy
EP3493855A4 (en) * 2016-08-02 2020-04-01 ISI Life Sciences, Inc. Compositions and methods for detecting cancer cells in a tissue sample

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
ATE198712T1 (en) * 1994-07-11 2001-02-15 Univ Texas METHODS AND COMPOSITIONS FOR THE SPECIFIC COAGULATION OF TUMOR VESSELS
TWI259837B (en) * 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis

Also Published As

Publication number Publication date
BG65682B1 (en) 2009-06-30
EP1532988A2 (en) 2005-05-25
WO2001023005A1 (en) 2001-04-05
EP1532988A3 (en) 2008-09-17
HK1050491A1 (en) 2003-06-27
BG106528A (en) 2002-12-29
CN1269530C (en) 2006-08-16
NO20021441L (en) 2002-05-15
EE05176B1 (en) 2009-06-15
DE19947559A1 (en) 2001-04-19
NZ517944A (en) 2004-06-25
AU6702600A (en) 2001-04-30
YU20702A (en) 2005-06-10
CZ2002991A3 (en) 2002-06-12
ZA200203225B (en) 2003-07-23
JP2003510294A (en) 2003-03-18
KR100832937B1 (en) 2008-05-27
BR0014192A (en) 2002-05-21
AU779026B2 (en) 2005-01-06
RU2002109237A (en) 2003-11-27
KR20020039349A (en) 2002-05-25
IL148405A0 (en) 2002-09-12
CA2385593A1 (en) 2001-04-05
SK3972002A3 (en) 2002-09-10
HUP0202625A2 (en) 2002-12-28
PL354027A1 (en) 2003-12-15
CN1376074A (en) 2002-10-23
NO20021441D0 (en) 2002-03-22
RO121598B1 (en) 2007-12-28
EP1214099A1 (en) 2002-06-19
IL148405A (en) 2009-06-15
MXPA02002639A (en) 2002-07-30
KR20070087232A (en) 2007-08-27

Similar Documents

Publication Publication Date Title
NO20014105D0 (en) Texan derivatives for targeted cancer therapy
PT1200065E (en) COMPOSITION OF INTRAVAGINAL CLINDAMYCINE OVULES
DE60002795D1 (en) Binder composition
DE60032887D1 (en) BIOPSY NEEDLE
EE200200673A (en) Quinazoline derivatives for the treatment of tumors
DE60026752D1 (en) Plow
NO20021400D0 (en) Therapeutic conazoline derivatives
NO20020037D0 (en) Procedures for avoiding weight gain
AU2291001A (en) Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
NO20022681D0 (en) Continuous preparation of silica-based microgels
ITMI991608A0 (en) ELECTROSURGICAL PROBE FOR THE TREATMENT OF TUMORS USING QUENZA RADIOFREENS
NO20014607L (en) Compositions for improving fertility
EE200200152A (en) Antibody-dye conjugates for binding to target angiogenesis structures for intraoperative visualization of peripheral tumors
NO974972D0 (en) Steps to prevent breast cancer
ATA198399A (en) HYDRAULIC ACTUATING ARRANGEMENT
ATA175199A (en) HYDRAULIC ACTUATING ARRANGEMENT
NO20021658L (en) asphalt inhibitors
NO20016151D0 (en) Preparation of substituted piperidin-4-ones
NO20020153L (en) Use of interleukin-18 inhibitors to inhibit tumor metastasis
ATA200899A (en) HYDRAULIC ACTUATING ARRANGEMENT
DE50008949D1 (en) Hydraulic expansion
PT1194426E (en) BENZOFURAN DERIVATIVES
DE60020047D1 (en) Binding for snowboard boots
DE29903391U1 (en) panty liner
ATA191899A (en) HYDRAULIC ACTUATING ARRANGEMENT

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20090819